Page 11 - Pharmaceuticals
Granules India bags exclusive rights for USpharma Windlas' four products
The Hyderabad-based company will have exclusive marketing rights to the US firm's fingolimod, prasugrel, dronedarone and lurasidone drugs
 "Granules India bags exclusive rights for USpharma Windlas' four products")
Global cancer treatment market to reach $ 150 bn by 2020: Study
The US now accounts for about 45% of the global oncology market, up from 39% in 2011, due to to the strengthening of the US dollar and rapid adoption of newer therapies, says a new IMS Health study
 "Global cancer treatment market to reach $ 150 bn by 2020: Study")
Strides Shasun receives US FDA's EIR report for Bangalore facility
The company's Bangalore facility manufactures oral dosage forms including tablets, capsules (both hard gelatine and soft gelatine)
 "Strides Shasun receives US FDA's EIR report for Bangalore facility")
Stempeutics gets DCGI nod to use stem cell therapy to fight Buerger's Disease
The company, a joint venture between Manipal Education and Cipla, has received approval to market Stempeucel product for treating Critical Limb Ischemia due to Buerger's Disease
 "Stempeutics gets DCGI nod to use stem cell therapy to fight Buerger's Disease")
Jubilant Life receives approval for epilepsy drug levetiracetam
The approved product, levetiracetam injection, is the generic version of UCB's Keppra injection
Dishman Pharma's Swiss arm Carbogen Amcis to expand operations
Carbogen Amcis will acquire GEA Pharma Systems' land and buildings in Bubendorf to significantly expand its laboratory capacity
 "Dishman Pharma's Swiss arm Carbogen Amcis to expand operations")
US FDA grants tentative approval to Strides Shasun's HIV drug efavirenz
The market for the approved product, efavirenz 600 mg tablet, is approximately $ 150 million in the US, as per IMS data
US FDA grants approval to Strides Shasun's antibacterial drug metronidazole
The approved product, metronidazole tablets 250 mg and 500 mg, will be manufactured at the company's oral dosage facility at Bangalore
 "US FDA grants approval to Strides Shasun's antibacterial drug metronidazole")
Cupid Ltd receives two orders worth Rs 101 million from UN arm
As per the order, the company will provide male and female condoms to United Nations Population Fund (UNFPA)
Lupin receives EIR from US FDA for Mandideep and Aurangabad facilities
In the Establishment Inspection Reports (EIR), the US drug regulator has announced closure of inspections for these two facilities
Alivira to buy majority stake in Spanish animal health firm Karizoo Group
With this deal, which makes Europe the largest market for Alivira, Sequent Scientific arm achieves critical size in global veterinary space with annualised revenue of $ 120 mn
 "Alivira to buy majority stake in Spanish animal health firm Karizoo Group")
Only a price controller
Pharmaceuticals department has achieved little
Piramal Enterprises strengthens OTC portfolio with Pfizer's four brands
The company to acquire Pfizer's four brands - Ferradol, Neko, Sloan's and Waterbury's Compound - for Rs 110 cr
 "Piramal Enterprises strengthens OTC portfolio with Pfizer's four brands")
Arbitration court asks former Ranbaxy owners to pay Rs 3,500 cr to Daiichi Sankyo
The court in Singapore ordered Malvinder Singh and Shivinder Mohan Singh to pay the fine for concealing key facts during the sale of Ranbaxy to Daiichi Sankyo in 2008
 "Arbitration court asks former Ranbaxy owners to pay Rs 3,500 cr to Daiichi Sankyo")
ICGEB and Sun Pharma to co-develop botanical drug for dengue
Sun Pharma to fund development programme as well pay royalty to International Centre for Genetic Engineering and Biotechnology (ICGEB), following commercialisation of the drug
 "ICGEB and Sun Pharma to co-develop botanical drug for dengue")
Indian drug units violate most US pharma regulators' rules
Country's drug factories rank among top in the US regulator's list in this regard, and we're talking of big names
 "Indian drug units violate most US pharma regulators' rules")
